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Abstract
Background: In subjects having a cesarean section, pain can increase hospital length of stay and postoperative complications. The
preventive analgesia in the postoperative phase is known to be more effective than analgesic treatment in response to pain.
Objectives: In this study, the analgesic efficacy of preventive intravenous acetaminophen was compared with placebo in relieving
postoperative pain after cesarean sections under spinal anesthesia.
Methods: In this double-blind randomized controlled study, 49 women undergoing elective cesarean section under spinal anes-
thesia were randomly allocated into two groups by block randomization in a referral hospital in Tehran in 2016. The intervention
group received intravenous acetaminophen (Apotel®) (1 gram) and the placebo group received normal saline on arrival to the re-
covery room within 20 minutes. Then the total consumed doses of meperidine, visual analogue scale (VAS) score of pain, and the
incidence of vomiting were determined and recorded for 24 hours postoperatively.
Results: Pain scores (VAS) were lower in the acetaminophen group throughout the study, but the difference was only significant
at forth to eighth hours after the surgery (P = 0.0001). The total consumed doses of meperidine to treat the pain was significantly
lower in the acetaminophen group at the fourth to the eighth hours after the surgery (P = 0.0001). The incidence of vomiting was
the same between the groups (P > 0.05).
Conclusions: A single dose preventive intravenous acetaminophen has good efficacy in reduction of postoperative pain and re-
duces opioid use after cesarean sections under spinal anesthesia up to 8 hours after the administration.
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1. Background
Postoperative pain has many physiological, immuno-
logical, and psychological adverse effects, and develop-
ment of chronic postsurgical pain is an unfortunate con-
sequence of surgery that adversely impacts the patient’s
quality of life (1). There are several methods for postopera-
tive pain management, including patient-controlled intra-
venous analgesia (PCIA), systemic analgesics, and regional
methods.
To administer the systemic analgesics, preemptive and
preventive analgesia methods are found to be more ef-
fective than the conventional method of postoperative
analgesic use (2). In this regard, Nonsteroidal anti-
inflammatory drugs (NSAIDs) or acetaminophen can be
mentioned. Acetaminophen is a central cyclooxygenase
(Cox3) inhibitor with less gastrointestinal side effects, anti-
platelet aggregation effects, and is better tolerated (2). Ow-
ing to the side effect profile of opioids, such as respiratory
depression, nausea, and vomiting, urinary retention, and
constipation, a multi-modal approach of analgesia is the
most common method of postoperative analgesia (3). The
use of acetaminophen would decrease opioid consump-
tion and prevent their side effects such as nausea and vom-
iting, hypotension, dizziness, prolonged bed rest, gastroin-
testinal problems.
In subjects having a cesarean section, pain can cause
an increase in hospital length of stay and also could be
a predisposing factor for other major complications such
as constipation, atelectasis, and deep vein thrombosis (4).
Analgesia after cesarean section is crucial to improve the
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satisfaction rate in patients and decrease the complica-
tions. In postoperative pain management in subjects hav-
ing a cesarean section, the neonatal concerns are also
an important issue in the determination of the analgesic
method. There are serious concerns about the adverse ef-
fects of postoperative mother’s pain on the mother and
neonate interactions and even long-term breastfeeding.
Therefore, pain management after caesarian section needs
special concern (5-7). The psychologic fragility of mother
and the necessity of wellbeing to care the neonate elicit
more concerns for pain management of obstetrics (8).
There are several studies about the efficacy of preventive
acetaminophen to reduce the postoperative opioid use,
nausea and vomiting, and postoperative pain; however,
there are few well-conducted randomized controlled trials
regarding this issue (9, 10) .
2. Objectives
In this study, the preventive analgesic efficacy of intra-
venous acetaminophen is compared with placebo in reliev-
ing postoperative pain after cesarean sections under spinal
anesthesia.
3. Methods
This is a double-blind randomized clinical trial study.
After approval of the Ethics Committee of Tehran Univer-
sity of Medical Sciences (IR.TUMS.MEDICINE.REC.1395.1119),
forty-nine full-term women aged between 18 to 40 years
were enrolled in this study who were candidates for elec-
tive cesarean section under spinal anesthesia in a referral
hospital in Tehran, in 2016.
The inclusion criteria were as follows: term parturient,
age range from 18 to 40 years, the American Society of Anes-
thesiologists (ASA) class 1 (healthy, non-smoking, no or
minimal alcohol use) and 2 (mild disease only without sub-
stantive functional limitations), BMI < 40 who were can-
didates to undergo elective cesarean section under spinal
anesthesia. The exclusion criteria were an operation du-
ration of more than 3 hours, need for additional surgery,
changing to general anesthesia or intraoperative opioid or
anesthetic use, substance abuse, chronic pain syndromes,
allergy to study medications, severe psychological disor-
ders, hepatic, renal and cardiac diseases, preeclampsia,
asthma, and an incision other than horizontal.
Helsinki declaration was applied to this study. All pa-
tients who fill the inclusion criteria and signed written
informed consent form were included in the study and
their demographic data were recorded. The patients were
assigned to randomized permuted block method (each
block with four patients) to receive either intravenous ac-
etaminophen (1 gram in 100 mL normal saline) manufac-
tured by UNIPHARMA company or placebo (100 mL normal
saline) received normal saline on arrival to the recovery
room within 20 minutes (50 mg/min). The primary out-
come was total postoperative use of meperidine to treat
the moderate or severe pains, visual analog scale (VAS)
score and the second outcome was the incidence of eme-
sis during the first 24 hours postoperatively. Before the
surgery, the VAS was explained to the patients (0 as no pain
and 10 as worst imaginable pain).
The study medications were prepared by an anesthesi-
ologist who did not participate in the study. They were en-
veloped, sealed, and labeled with the patient’s code. The
envelopes were opened in the operating room before start-
ing anesthesia by an anesthesiologist who was blinded to
the patient study group and type of solution. On the day
of the surgery, after arrival in the operating room, intra-
venous access was established and ECG, pulse oximeter,
and non-invasive blood pressure monitoring were estab-
lished. The anesthesia method was the same in all patients
and spinal anesthesia was performed with a quincke 27-
gauge needle with 12.5 mg bupivacaine 0.5% in the sitting
position at the L3 - L4 or L4 - L5 interspaces. No sedative
or dexamethasone was used during the surgery and all of
the patients received 4 mg intravenous ondansetron af-
ter spinal anesthesia. The patients in the acetaminophen
group received intravenous acetaminophen (Apotel®) (1
gram in 100 mL normal saline) and the patients in the
placebo group received 100 mL normal saline in the re-
covery room. Postoperatively, all patients with VAS more
than 3 received 100 mg diclofenac suppository and the pa-
tients with persistent VAS more than 3 received 25 mg in-
travenous meperidine up to maximum 200 mg within 24
hours. All of the data were recorded on a coded question-
naire, VAS, and opioid consumption was assessed at 0 (at
arrival to recovery), 4, 8, 12, 24 hours postoperatively in the
two groups. Also, the rate of vomiting was determined and
compared across the groups at the same time. All of the
data were collected by a nurse who was blinded to the pa-
tient group.
Data analysis was performed among 49 subjects, in-
cluding 29 patients in the control group and 20 subjects
in the intervention group by SPSS (version 23.0) software
[Statistical Procedures for Social Sciences; Chicago, Illinois,
USA]. Chi-square, Fisher’s exact, and Independent sample
t-test analyses were done and P values less than 0.05 were
considered statistically significant.
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4. Results
A total of 49 patients over a period of 6 months re-
mained in the study after applying the exclusion criteria.
There was no difference between the two groups with
regard to demographic characteristics (Table 1).
The meperidine usage was significantly lower in the ac-
etaminophen group at 4 - 8 hours in comparison to the
placebo group (P = 0.000) (Table 2).
As shown in Figure 1 and Table 3, there was a lower
pain (VAS) in the acetaminophen group throughout the
study, but the difference was only significant at forth to the
eighth hours after the surgery (P = 0.000).
The incidence of vomiting was statistically similar be-
tween the groups and only one patient vomited in the con-
trol group (P = 1.000)
5. Discussion
Cesarean section is a common surgical procedure
ranging from 19 to 58 percent worldwide (10, 11). The indi-
cations to perform this method are comprised of repeated
Table 1. The Comparison of Independent Variables Between the Two Groups
Acetaminophen Control P Value
Age, y 31.70 ± 1.5 32.24 ± 2 0.70
Gestational age, week 38.19 ± 1.5 38.41 ± 1.2 0.50
Height, cm 163.00 ± 4 164.20 ± 5 0.21
Duration of surgery, min 71.70 ± 11.5 70.05 ± 1.5 0.24
Table 2. Percentage and Number of Patients with Meperidine Injection Between the
Study Groups
Time Intervals, h
Patient with Meperidine Injectiona
P Value
Acetaminophen Control
0 - 4 1 (5) 6 (20.7) 0.216
4 - 8 2 (10) 18 (62.1) < 0.001
8 - 12 7 (35) 11 (37.9) 0.834
12 - 24 2 (10) 1 (3.4) 0.559
aValues are expressed as No. (%).
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Figure 1. Pain is shown in the two groups during the study. A, acetaminophen group;
B, normal saline group
cesarean section, fetal distress, lack of labor progression,
cephalopelvic disproportion (CPD), abnormal presenta-
tion, and hemorrhage (12). Despite the high safety of ce-
sarean section, some adverse effects may be seen, which are
more common in urgent procedures (12). Pain, bleeding,
and infection are important concerns in cesarean section
(10-13), which could decrease the satisfaction rate among
the patients (14). Uncontrolled acute postoperative pain is
associated with dissatisfaction and postoperative compli-
cations and is a strong risk factor for the development of
chronic pain (15).
Preventive analgesia (analgesic before pain onset) has
evolved from preemptive analgesia (analgesic before the
surgical event), both have some advantages over the con-
ventional treatment of pain (2). In this study, the preven-
tive analgesic efficacy of intravenous acetaminophen was
compared with placebo for postoperative analgesia in ce-
sarean sections under spinal anesthesia.
Soltani et al. (16) reported that intravenous ac-
etaminophen had higher efficacy for reduction of pain and
opioid use in cesarean section in comparison to placebo
and their results were similar to this study. Abu Omar and
Awwad al Issa (17) assessed the efficacy of acetaminophen
in cesarean section and it was seen that the use of this
method led to lower opioid consumption as the results of
this study showed. Ozmet et al. (18) reported the efficacy
of preoperative use of single-dose intravenous 1 g paraceta-
mol in decreasing the opioid consumption and the sever-
ity of pain in the first 24 hours in subjects having a cesarean
section.
In a comparison of preemptive and preventive in-
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travenous paracetamol for pediatric dental surgeries,
Kharouba et al. (19) indicated postoperative pain scores
and opioid use were decreased in the preemptive IV parac-
etamol group in comparison to the preventive group.
However, Imani et al. (20) in a study compared the effect
of adding dexmedetomidine to paracetamol and ketoro-
lac to control the postoperative pain in subjects having a
cesarean section. They reported that the opioid use was
slightly higher in the paracetamol group, and also the sat-
isfaction was lower significantly in the paracetamol group.
Cattabriga et al. (21) assessed the efficacy of intra-
venous acetaminophen for cardiac surgery and it resulted
in reducing the pain at 12, 18, and 24 hours after the op-
eration. However, the opioid use was similar between the
groups. Their results were generally consistent with the
present study. Another study (22) reported lower pain af-
ter cesarean and lower tramadol use with the use of intra-
venous acetaminophen as we found in this study. Shimia et
al. (23) assessed the efficacy of intravenous acetaminophen
versus placebo for lumbar surgery and found that pain
severity and analgesic use was lower in acetaminophen
groups as we advocated in the current study. Jarineshin et
al. (24) indicated that the meperidine decreased postop-
erative pain score and analgesic consumption more than
paracetamol; however, it increased the vomiting score.
In the present study, we showed there were lower opi-
oid consumption and VAS scores in the acetaminophen
group, but the difference was only significant at forth to
the eighth hours after the surgery. This time-limited effi-
cacy could be matched with pharmacological properties of
acetaminophen. On the other hand, vomiting was similar
between the groups.
5.1. Limitations
This study used a single dose of acetaminophen and
was held in one particular ethnic group in one medical
center with particular medical protocols. Further studies
with repeated doses in higher sample size to evaluate other
secondary variables could enhance the utility of evidence-
based outcomes.
5.2. Conclusion
We demonstrated preventive intravenous ac-
etaminophen had better efficacy in the reduction of
postoperative pain and opioid consumption after ce-
sarean sections under spinal anesthesia in a limited time
interval.
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